MorphoSys Financial Statements From 2010 to 2024

MOR Stock  USD 18.14  0.04  0.22%   
MorphoSys financial statements provide useful quarterly and yearly information to potential MorphoSys AG ADR investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MorphoSys financial statements helps investors assess MorphoSys' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MorphoSys' valuation are summarized below:
Gross Profit
229.6 M
Profit Margin
(0.80)
Market Capitalization
2.7 B
Enterprise Value Revenue
11.2833
Revenue
238.3 M
There are over one hundred nineteen available fundamental ratios for MorphoSys, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to check MorphoSys' last-minute fundamental performance against the performance between 2010 and 2024 to make sure the trends are evolving in the right direction.
Check MorphoSys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MorphoSys main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.4 M, Interest Expense of 115.4 M or Selling General Administrative of 90.5 M, as well as many exotic indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0 or Operating Cycle of 431. MorphoSys financial statements analysis is a perfect complement when working with MorphoSys Valuation or Volatility modules.
  
This module can also supplement various MorphoSys Technical models . Check out the analysis of MorphoSys Correlation against competitors.

MorphoSys Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.1 BB963.3 M
Slightly volatile
Total Current Liabilities277.5 M264.3 M110 M
Slightly volatile
Total Stockholder Equity46.6 M49 M284 M
Very volatile
Property Plant And Equipment Net11.8 M15 M14.3 M
Slightly volatile
Accounts Payable14.7 M28.4 M17.2 M
Slightly volatile
Cash166.4 M158.5 M99.8 M
Slightly volatile
Non Current Assets Total1.3 B1.2 B440.9 M
Slightly volatile
Non Currrent Assets Other1.2 M1.2 M4.8 M
Pretty Stable
Cash And Short Term Investments716.9 M682.8 M407.7 M
Slightly volatile
Common Stock Total Equity34.8 M37.8 M28.7 M
Slightly volatile
Common Stock Shares Outstanding108.5 M137.3 M110.8 M
Slightly volatile
Liabilities And Stockholders Equity2.1 BB963.3 M
Slightly volatile
Non Current Liabilities Total1.8 B1.7 B569.1 M
Slightly volatile
Other Stockholder Equity982.9 M936.1 M514.5 M
Slightly volatile
Total Liabilities2.1 BB679 M
Slightly volatile
Total Current Assets854.7 M814 M522.4 M
Slightly volatile
Intangible Assets886.3 M844.1 M262.6 M
Slightly volatile
Common Stock35.4 M37.7 M29 M
Slightly volatile
Net Receivables83.8 M42.7 M81.4 M
Pretty Stable
Inventory65.2 M62.1 M12.6 M
Slightly volatile
Short and Long Term Debt Total667.7 M635.9 M155.4 M
Slightly volatile
Good Will359.4 M342.3 M100.5 M
Slightly volatile
Current Deferred Revenue18.4 M17.5 M6.4 M
Slightly volatile
Short Term Investments372.9 M524.3 M306.7 M
Slightly volatile
Short Term Debt14.2 M14.1 M16.6 M
Pretty Stable
Other LiabilitiesB1.9 B539.1 M
Slightly volatile
Property Plant Equipment61.6 M58.6 M24.1 M
Slightly volatile
Net Invested Capital595.3 M672.6 M459.6 M
Slightly volatile
Net Working Capital643.2 M549.7 M452.5 M
Slightly volatile
Capital Stock37.2 M37.7 M33 M
Slightly volatile

MorphoSys Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization10.4 M10.5 M12.2 M
Slightly volatile
Interest Expense115.4 M109.9 M41.6 M
Slightly volatile
Selling General Administrative90.5 M86.2 M37.2 M
Slightly volatile
Total Revenue250.2 M238.3 M130.4 M
Slightly volatile
Gross Profit96.7 M179.9 M108.9 M
Slightly volatile
Other Operating Expenses513.6 M489.1 M216 M
Slightly volatile
Research Development297.8 M283.6 M131.4 M
Slightly volatile
Total Operating Expenses452.3 M430.8 M200.6 M
Slightly volatile
Interest Income16.5 M18.3 M9.5 M
Slightly volatile
Reconciled Depreciation8.4 M10.5 MM
Slightly volatile
Selling And Marketing ExpensesM6.3 M21.9 M
Slightly volatile

MorphoSys Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow422.5 M402.4 M109.5 M
Slightly volatile
DepreciationM10.5 M6.1 M
Slightly volatile
Capital Expenditures2.7 M2.9 M10.7 M
Pretty Stable
End Period Cash Flow85.1 M158.5 M94.4 M
Slightly volatile
Stock Based Compensation28.7 M27.4 M7.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.95.159127.7661
Slightly volatile
Dividend Yield0.00.00.001
Slightly volatile
Operating Cycle4314542.3 K
Slightly volatile
Price Book Value Ratio15.2525.062411.6858
Pretty Stable
Ebt Per Ebit1.060.75620.9581
Pretty Stable
Company Equity Multiplier43.3841.31188.3724
Slightly volatile
Long Term Debt To Capitalization0.970.92690.2383
Slightly volatile
Cash Per Share5.224.97453.2159
Slightly volatile
Total Debt To Capitalization0.970.92840.2697
Slightly volatile
Debt Equity Ratio13.6112.96522.0783
Slightly volatile
Quick Ratio5.012.74456.1283
Pretty Stable
Cash Ratio0.570.59971.3538
Slightly volatile
Days Of Sales Outstanding62.0765.3394345
Slightly volatile
Price To Book Ratio15.2525.062411.6858
Pretty Stable
Current Ratio2.933.07986.7272
Slightly volatile
Fixed Asset Turnover11.7415.894815.7462
Slightly volatile
Debt Ratio0.330.31380.108
Slightly volatile
Price Sales Ratio4.95.159127.7661
Slightly volatile
Receivables Turnover3.035.58622.2976
Slightly volatile
Asset Turnover0.110.11760.1882
Slightly volatile
Gross Profit Margin1.070.75510.9661
Slightly volatile
Price Fair Value15.2525.062411.6858
Pretty Stable

MorphoSys Fundamental Market Drivers

Forward Price Earnings322.5806
Cash And Short Term Investments682.8 M

MorphoSys Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MorphoSys Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include MorphoSys income statement, its balance sheet, and the statement of cash flows. MorphoSys investors use historical funamental indicators, such as MorphoSys's revenue or net income, to determine how well the company is positioned to perform in the future. Although MorphoSys investors may use each financial statement separately, they are all related. The changes in MorphoSys's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MorphoSys's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MorphoSys Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MorphoSys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue17.5 M18.4 M
Total Revenue238.3 M250.2 M
Cost Of Revenue58.4 M61.3 M
Ebit Per Revenue(1.06)(1.01)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MorphoSys AG ADR is a strong investment it is important to analyze MorphoSys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MorphoSys' future performance. For an informed investment choice regarding MorphoSys Stock, refer to the following important reports:
Check out the analysis of MorphoSys Correlation against competitors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for MorphoSys Stock analysis

When running MorphoSys' price analysis, check to measure MorphoSys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MorphoSys is operating at the current time. Most of MorphoSys' value examination focuses on studying past and present price action to predict the probability of MorphoSys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MorphoSys' price. Additionally, you may evaluate how the addition of MorphoSys to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Transaction History
View history of all your transactions and understand their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Is MorphoSys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MorphoSys. If investors know MorphoSys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MorphoSys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.87)
Earnings Share
(1.50)
Revenue Per Share
1.736
Quarterly Revenue Growth
(0.28)
Return On Assets
(0.07)
The market value of MorphoSys AG ADR is measured differently than its book value, which is the value of MorphoSys that is recorded on the company's balance sheet. Investors also form their own opinion of MorphoSys' value that differs from its market value or its book value, called intrinsic value, which is MorphoSys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MorphoSys' market value can be influenced by many factors that don't directly affect MorphoSys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MorphoSys' value and its price as these two are different measures arrived at by different means. Investors typically determine if MorphoSys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MorphoSys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.